Kodak reported consolidated revenues of $290 million in the fourth quarter of 2025, compared with $266 million in the year-ago period, an increase of $24 million or 9%.
uniQure said the FDA does not agree that Phase I/II data are sufficient to serve as primary evidence of effectiveness for a marketing application for its Huntington’s disease gene therapy, AMT-130.
Gorilla Technology executives revealed to investors at an investor event that the company entered 2026 with a contracted backlog of more than $100 million.
Last week, we unveiled ValuEngine's top ten stocks for 2025. Now we profile top-ranked ETFs that hold the most major positions in each of these stocks,
The $45 million purchase was financed using the company’s available cash, which stood at $61.3 million as of the end of March, bolstered by proceeds from its at-the-market equity offering.
CHMP has recommended that the European Commission approve the therapy for treating adult patients over the age of 26 with relapsed or refractory B-cell precursor acute Lymphoblastic Leukemia.
The temporary U.S. layoffs affect factories in Michigan and Indiana, while the Ontario plant in Canada will shut down for two weeks, and the Toluca facility in Mexico will remain closed through April.
The company reported a full-year 2024 net profit of €5.47 billion ($5.72 billion), down from €18.6 billion a year earlier, with EPS falling to €1.84 from €5.94.
